OmanDocSign in

Curriculum · Gastroenterology

Autoimmune hepatitis

What it is

Autoimmune hepatitis is an autoimmune disease of the liver. It is common in females and primarily develops in women aged 20 to 40 years, and it is associated with other autoimmune disease: 50% of patients have another one, such as thyroiditis, ulcerative colitis or synovitis.

Hepatocellular injury is what it does, and liver failure is where it ends. The autoimmune conditions it is associated with are named: DM-1, celiac disease, Graves, vitiligo and ulcerative colitis.

How it presents

The liver injury is hepatocellular. The clinical presentation ranges from an asymptomatic elevation of aminotransferase levels to acute liver failure, so it may be found on a routine blood test or in a patient who already has liver failure.

The symptoms divide in two. Non-specific: fatigue and weight loss. Hepatic: jaundice, RUQ pain, fever, hepatomegaly, splenomegaly and ascites.

How it is diagnosed

The serologic picture is:

On a serology panel, anti-nuclear antibodies, smooth muscle antibodies and liver-kidney-microsome antibodies are the markers of autoimmune hepatitis, while anti-mitochondrial antibodies belong to primary biliary cirrhosis instead.

Liver biopsy establishes the diagnosis, and it is indicated in all cases. One clue is easy to miss: a high serum total protein with a low serum albumin suggests an elevated serum gamma globulin level, and may be the only sign of hypergammaglobulinemia.

Set out as a short list, the diagnosis rests on four things: aminotransferases, ALT and AST, raised 10 to 20 times above normal; serum protein electrophoresis showing hypergammaglobulinemia with a raised IgG, and a raised ESR; serology, that is ANA and anti smooth muscle antibody for type 1, in children and adults, and anti liver kidney microsomal antibody, anti-LKM-1, for type 2, in children; and liver biopsy, whose histology is lymphoplasmacytic interface hepatitis.